A method for administration of ibuprofen to a subject in need of ibuprofen treatment is provided in which an oral dosage form comprising a therapeutically effective amount of ibuprofen and a therapeutically effective amount of famotidine is administered three times per day.

A method for administration of ibuprofen to a subject in need of ibuprofen treatment is provided in which an oral dosage form comprising a therapeutically effective amount of ibuprofen and a therapeutically effective amount of famotidine is administered three times per day.

Pharmaceutical compositions of a H2 receptor antagonist and ibuprofen are provided herein. The compositions comprise e.g. a core and a shell separated by a barrier layer bilayered or trilayered compositions or liquid formulations. Also provided are methods of making the pharmaceutical compositions and methods of treatment comprising administering the pharmaceutical compositions. Also provided is a method for administration of ibuprofen to a subject in need of ibuprofen treatment is provided in w...

PROBLEM TO BE SOLVED: To prepare a parenteral injection solution which comprises famotidine sparingly soluble in a neutral or an alkaline region and is stable for a long period at room temperature.SOLUTION: This parenteral injection solution at about pH 5.5-6.5 comprises famotidin and phosphoric acid.COPYRIGHT: (C)2003JPO

A method for administration of ibuprofen to a subject in need of ibuprofen treatment is provided in which an oral dosage form comprising a therapeutically effective amount of ibuprofen and a therapeutically effective amount of famotidine is administered three times per day.

Stable pharmaceutical compositions of famotidine and ibuprofen in a single unit dosage form are disclosed herein. The compositions comprise a famotidine core having a reduced or minimal surface area surrounded by a layer of ibuprofen. In some embodiments the ibuprofen is in direct physical contact with the famotidine.

The present invention provides to methods and compositions that treat or prevent deleterious effects associated with alcohol consumption including alcohol-induced flush reaction and hangover. The methods and compositions include famotidine and optionally succinic acid. The present invention further demonstrates compositions that include famotidine are effective at treating symptoms associated with a flush reaction in subjects that are not significantly responsive to treatments with the H1 antago...

PURPOSE: A composition containing ecabet sodium and famotidine is provided to treat gastrointestinal diseases with storage stability and to enhance drug effects. CONSTITUTION: A composition for treating gastrointestinal diseases contains 1-20 wt% of ecabet sodium and 0.01-5 wt% of famotidine. The composition further contains pH adjusting agent and pharmaceutically acceptable additives. The composition is manufactured in the form of suspension. The suspension formulation contains ecabet sodium fa...